ATE214375T1 - Piperazinylalkylthiopyrimidin derivate, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung - Google Patents
Piperazinylalkylthiopyrimidin derivate, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellungInfo
- Publication number
- ATE214375T1 ATE214375T1 AT96935194T AT96935194T ATE214375T1 AT E214375 T1 ATE214375 T1 AT E214375T1 AT 96935194 T AT96935194 T AT 96935194T AT 96935194 T AT96935194 T AT 96935194T AT E214375 T1 ATE214375 T1 AT E214375T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- pharmaceutical compositions
- compositions containing
- production
- derivatives
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000009543 pathological alteration Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9503099A HUT76266A (en) | 1995-10-31 | 1995-10-31 | New piperazinyl-alkylthio-pyrimidine derivatives, pharmaceutical compositions containing them, and process for producing the active components |
| PCT/HU1996/000061 WO1997016429A1 (en) | 1995-10-31 | 1996-10-25 | Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE214375T1 true ATE214375T1 (de) | 2002-03-15 |
Family
ID=10987317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96935194T ATE214375T1 (de) | 1995-10-31 | 1996-10-25 | Piperazinylalkylthiopyrimidin derivate, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6130215A (de) |
| EP (1) | EP0901473B1 (de) |
| JP (1) | JPH11514641A (de) |
| KR (1) | KR19990067137A (de) |
| CN (1) | CN1207733A (de) |
| AT (1) | ATE214375T1 (de) |
| AU (1) | AU707166B2 (de) |
| CZ (1) | CZ112198A3 (de) |
| DE (1) | DE69619868T2 (de) |
| HU (1) | HUT76266A (de) |
| NZ (1) | NZ320522A (de) |
| PL (1) | PL327461A1 (de) |
| SK (1) | SK283489B6 (de) |
| WO (1) | WO1997016429A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4425143A1 (de) * | 1994-07-15 | 1996-01-18 | Basf Ag | Substituierte Pyrimidinverbindungen und deren Verwendung |
| PT1194415E (pt) | 1999-06-29 | 2004-01-30 | Egyt Gyogyszervegyeszeti Gyar | Novos derivados da piperazinil-alquil-tiopirimidina composicoes farmaceuticas que os contem e um processo de preparacao da substancia activa |
| PE20020063A1 (es) | 2000-06-20 | 2002-01-30 | Upjohn Co | Bis-arilsulfonas como ligandos del receptor de 5-ht |
| US20040014966A1 (en) * | 2000-06-20 | 2004-01-22 | Jacobsen Eric Jon | Bis-arylsulfones |
| US6586592B2 (en) | 2000-06-20 | 2003-07-01 | Pharmacia & Upjohn Company | Bis-arylsulfones |
| DE112009001776B4 (de) | 2008-07-30 | 2021-01-21 | Asahi Kasei Chemicals Corporation | Verfahren zur Herstellung von Cycloolefin und Vorrichtung zur Herstellung desselben |
| US10315655B2 (en) | 2017-03-07 | 2019-06-11 | Deere & Company | Vehicle control based on soil compaction |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE792206A (de) * | 1971-12-02 | 1973-06-01 | Byk Gulden Lomberg Chem Fab | |
| EP0202654A3 (de) * | 1985-05-20 | 1987-12-16 | E.R. Squibb & Sons, Inc. | 5-Carboxy-1,4-dihydropyrimidinderivate |
-
1995
- 1995-10-31 HU HU9503099A patent/HUT76266A/hu unknown
-
1996
- 1996-10-25 WO PCT/HU1996/000061 patent/WO1997016429A1/en not_active Application Discontinuation
- 1996-10-25 SK SK475-98A patent/SK283489B6/sk unknown
- 1996-10-25 EP EP96935194A patent/EP0901473B1/de not_active Expired - Lifetime
- 1996-10-25 AU AU73262/96A patent/AU707166B2/en not_active Ceased
- 1996-10-25 US US09/066,465 patent/US6130215A/en not_active Expired - Fee Related
- 1996-10-25 NZ NZ320522A patent/NZ320522A/xx unknown
- 1996-10-25 KR KR1019980703083A patent/KR19990067137A/ko not_active Application Discontinuation
- 1996-10-25 PL PL96327461A patent/PL327461A1/xx unknown
- 1996-10-25 AT AT96935194T patent/ATE214375T1/de not_active IP Right Cessation
- 1996-10-25 DE DE69619868T patent/DE69619868T2/de not_active Expired - Fee Related
- 1996-10-25 CN CN96198654A patent/CN1207733A/zh active Pending
- 1996-10-25 JP JP9517175A patent/JPH11514641A/ja active Pending
- 1996-10-25 CZ CZ981121A patent/CZ112198A3/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUT76266A (en) | 1997-07-28 |
| EP0901473A1 (de) | 1999-03-17 |
| PL327461A1 (en) | 1998-12-07 |
| JPH11514641A (ja) | 1999-12-14 |
| SK47598A3 (en) | 1998-12-02 |
| DE69619868T2 (de) | 2002-10-10 |
| NZ320522A (en) | 1999-03-29 |
| KR19990067137A (ko) | 1999-08-16 |
| AU7326296A (en) | 1997-05-22 |
| SK283489B6 (sk) | 2003-08-05 |
| US6130215A (en) | 2000-10-10 |
| WO1997016429A1 (en) | 1997-05-09 |
| AU707166B2 (en) | 1999-07-01 |
| CN1207733A (zh) | 1999-02-10 |
| DE69619868D1 (de) | 2002-04-18 |
| HU9503099D0 (en) | 1995-12-28 |
| EP0901473B1 (de) | 2002-03-13 |
| CZ112198A3 (cs) | 1998-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69723869D1 (de) | Heterozyklische verbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen die diese enthalten und ihre anwendung in der behandlung von diabetis und verwandten krankheiten | |
| MA27676A1 (fr) | 2-amino-6-(2-substitue-4-phenoxy)-substitue-pyridines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| CA2176668A1 (fr) | Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant | |
| ATE247645T1 (de) | Neue piperazinylalkylthiopyrimidine derivate, diese enthaltende pharmazeutische zusammenstellungen und verfahren zu deren herstellung | |
| DE69526726T2 (de) | Tetrasubstituierte imidazolderivate, verfahren zu ihrer herstellung, ihre anwendung als medikamente und diese enthaltende pharmazeutischen zusammensetzungen | |
| ATE214375T1 (de) | Piperazinylalkylthiopyrimidin derivate, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung | |
| ATE85334T1 (de) | Bisphenylalkylpiperazin-derivate, verfahren zur herstellung und arzneimittelzubereitung. | |
| DK0823909T3 (da) | Hidtil ukendte heterocykliske forbindelser | |
| ATE417831T1 (de) | Ceramid ähnliche verbindungen, verfahren zu deren herstellung und deren verwendung als antitumormittel | |
| BR9610175A (pt) | Composto processo de preparação do composto composição farmacêutica e utilização do composto | |
| DE69917668D1 (de) | Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung | |
| ATE421961T1 (de) | Piperidinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzung zur behandlung von alzheimer-krankheit, die diese derivate enthält | |
| ATE73807T1 (de) | Neue benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte. | |
| ES2137665T3 (es) | Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos. | |
| DE59606725D1 (de) | Substituierte phenylamidine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung | |
| ES2123796T3 (es) | Derivados de acidos fosfono-succinicos y su utilizacion como medicamentos. | |
| ATE69809T1 (de) | Leukotrienantagonisten, verfahren zu ihrer herstellung, ihre anwendung zur behandlung von krankheiten. | |
| DE59504643D1 (de) | Neue phosphanoxide, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel | |
| IT1258788B (it) | Derivati solforati di acidi biliari | |
| PT950053E (pt) | Novos derivados de benzoilalquil-1,2,3,6-tetra-hidropiridinas | |
| ATE168697T1 (de) | Pyrrolidinderivate zur behandlung von cck und gastrin-abhängigen erkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |